Arcutis Biotherapeutics (ARQT) Gross Profit (2022 - 2026)
Arcutis Biotherapeutics' Gross Profit was $118.92 million in Q2 2026, up 60.7% from $74.01 million a year earlier and up 24.4% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Gross Profit (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcutis Biotherapeutics' Gross Profit was $422.89 million through Jun 30, 2026, up 80.2% year-over-year; for FY2025, it was $339.38 million, up 91.3% from FY2024.
- Gross Profit shows a three-year compound annual growth rate of 387.3% (FY2022 to FY2025).
- In earlier years, Gross Profit was $177.41 million in FY2024 (+224.8%), $54.62 million in FY2023 and $2.93 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q3 2022.
- Compared with a year earlier, Gross Profit has increased for nine straight quarters, with growth averaging 126.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 6.3% (Q3 2024) to 520.6% (Q2 2024).
- Per Business Quant data, ARQT's Gross Profit in the three quarters before Q2 2026 was $95.61 million (Q1 2026), $117.82 million (Q4 2025) and $90.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arcutis Biotherapeutics | 3.32 Bn | 2.60 Bn | 118.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.92 Mn |
| Mar 31, 2026 | 95.61 Mn |
| Dec 31, 2025 | 117.82 Mn |
| Sep 30, 2025 | 90.53 Mn |
| Jun 30, 2025 | 74.01 Mn |
| Mar 31, 2025 | 57.02 Mn |
| Dec 31, 2024 | 64.46 Mn |
| Sep 30, 2024 | 39.25 Mn |
| Jun 30, 2024 | 27.39 Mn |
| Mar 31, 2024 | 46.31 Mn |
| Dec 31, 2023 | 11.28 Mn |
| Sep 30, 2023 | 36.93 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 456,000.00 |
API Access
Arcutis Biotherapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();